Drugs Information:
Bictegravir
Basic Information
|
|
||
| ID | DDInter205 | |
| Drug Type | small molecule | |
| Molecular Formula | C21H18F3N3O5 | |
| Molecular Weight | 449.386 | |
| CAS Number | 1611493-60-7 | |
| Description | Bictegravir is a recently approved investigational drug that has been used in trials studying the treatment of HIV-1 and HIV-2 infection. It has been approved for HIV-1 monotherapy combined with 2 other antiretrovirals in a single tablet.[L43677] | |
| ATC Classification | J05AR20 | |
| IUPAC Name | (1S,11R,13R)-5-hydroxy-3,6-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-12-oxa-2,9-diazatetracyclo[11.2.1.0^{2,11}.0^{4,9}]hexadeca-4,7-diene-7-carboxamide | |
| InChI | SOLUWJRYJLAZCX-LYOVBCGYSA-N | |
| Canonical SMILES | OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O | |
| Useful Links | DrugBank ChEBI PubChem Substance ChemSpider BindingDB Wikipedia ChEMBL | |
Interactions with
Bictegravir
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|